Skip to content

REVB

REVELATION BIOSCIENCES, INC.

NASDAQ · Healthcare · Biotechnology · US

$0.93
−2.06%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 5, 2026
EPS estimate
-$0.88
Revenue estimate

Latest reported

Last report date
Aug 7, 2026
EPS actual
-$0.87
EPS estimate
-$0.88
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
6
EPS misses (12Q)
5
EPS in line (12Q)
1
Avg surprise (4Q)
-56.1%
Revenue beats (12Q)
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 7, 2026-$0.88-$0.87Beat 0.57%
May 7, 2026-$1.15-$2.71Miss -135.65%
Nov 6, 2025-$5.36-$7.08Miss -32.09%
Aug 7, 2025-$4.46-$7.01Miss -57.17%
May 8, 2025-$21-$6.33Beat 69.33%
Mar 6, 2025-$9.60-$15Miss -55.63%$27.0K
Nov 8, 2024-$136-$40Beat 70.42%
Aug 9, 2024-$87-$74Beat 14.92%
May 10, 2024-$259-$118Beat 54.36%
Mar 22, 2024-$525-$400Beat 23.86%$37.6K
Nov 9, 2023-$432-$591Miss -36.67%
Aug 11, 2023-$476-$360Beat 24.24%

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026